Tag: Leppert
GeNeuro appoints Anke Post as Medical Director, following the retirement of David Leppert, who becomes a consultant for GeNeuro – 01/05/2024 at 6:00 p.m.
Geneva, Switzerland, January 5, 2024 – 6:00 p.m. CET – GeNeuro (Euronext Paris: CH0308403085 – GNRO), biopharmaceutical company whose objective is to stop the progression of neurodegenerative and autoimmune diseases…